Notícias e Atividades da Aspira Women’s Health

Aspira Women’s Health é uma empresa listada sob o símbolo AWH (US).

Veja o organograma con seus 15 executivos principais

Biografias mais buscadas da Aspira Women’s Health

• Jack Fraser, Interim Chief Executive Officer and Chairman of the B...
• Jeffrey Cohen, Director
• Jane Wood, Director

Recentes movimentos de executivos em Aspira Women’s Health

• Jack Fraser antes Chairman of the Board, agora é Interim Chief Executive Officer and Chairman of the Board  (Notícia publicada em 23 de junho de 2026).
• Mike Buhle, Chief Executive Officer, deixou a Companhia  (Notícia publicada em 23 de junho de 2026).
• John Strahley, ingressou na Companhia como Chief Financial Officer  (Notícia publicada em 31 de maio de 2026).

Criar um alerta
para seguir os movimentos de executivos da Aspira Women’s Health.

Aspira Women’s Health possui 1.244 concorrentes concorrentes Thermo Fisher Scientific (Estados Unidos), Cytiva (Estados Unidos) e Philips (Holanda).

Popular M&A news in Equipamentos Médicos

• Think Surgical acaba de anunciar uma arrecadação de fundos de 65 milhões de dólares. (publicado em 16 de julho de 2026).
• Pearl Health acaba de anunciar uma arrecadação de fundos de 110 milhões de dólares. (publicado em 12 de julho de 2026).
• EQT has announced the acquisition of Corza Medical  (publicado em 9 de julho de 2026).

Outros contatos sugeridos na indústria do Equipamentos Médicos

• Ivan Tornos - Chairman, President and Chief Executive Officer da Zimmer Biomet
• Kevin Lobo - President, Chief Executive Office & Chairman of the Board da Stryker
• Marc Casper - Chairman of the Board, President and Chief Executive Officer da Thermo Fisher Scientific

Saiba mais sobre a indústria do Equipamentos Médicos

Últimos comunicados de imprensa de Aspira Women’s Health

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• View more press releases Close

Redes sociais sobre Aspira Women’s Health

• Aspira Women’s Health na Wikipedia, Google News e Yahoo Finance
• Aspira Women’s Health na LinkedIn, X (Twitter) e YouTube